February 5, 2026 | Women in Leadership, Women in healthcare
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an “epidemic hiding in plain sight”. Perhaps most staggering is that 90% of women with the condition are undiagnosed. In the latest Hear From Her podcast, host Jovana Lubarda, PhD, joins Dr. Kimberly Sterling and Dr. Audrey Wells to discuss why women are slipping through the diagnostic cracks.

Listen to the full episode here.
The “Invisible” Symptoms
The traditional “poster child” for OSA is a middle-aged man who snores loudly, but these symptoms often do not apply to women. Dr. Wells and Dr. Sterling, both of whom are OSA patients themselves, highlight that women’s symptoms are often subtle and non-specific:
Listen to the full episode here.
Why Treatment Matters
Untreated OSA is a breathing disorder that erodes brain, heart, and metabolic health. However, modern CPAP technology is now quiet, travel-friendly, and customized. Research even suggests that CPAP treatment can lead to a 37% lower risk of all-cause mortality and a 55% lower risk of cardiovascular mortality.
“Until you look, you don’t actually know,” warns Dr. Wells. By advocating for your own sleep health, you can move past the exhaustion and reclaim your vitality.
Listen to the full episode now to learn how to stop overexplaining your exhaustion and start reclaiming your vitality.
Follow us for updates on upcoming podcasts and more insightful conversations.
For more information, please contact Jelena Spyropoulos.
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses for physicians, nurses, and other healthcare professional
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven…
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical…
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health….
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in…
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an “epidemic hiding in plain sight”. Perhaps most staggering is that 90% of women with…
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at…
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their…
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more…
